What is the catalog number for CoV-2 S1 (16-685) Protein?

The catalog number for CoV-2 S1 (16-685) Protein is orb753217.

What sizes are available for CoV-2 S1 (16-685) Protein?

CoV-2 S1 (16-685) Protein is available in the following size(s): 2 µg, 10 µg, 1 mg.

How many pack sizes does CoV-2 S1 (16-685) Protein come in?

CoV-2 S1 (16-685) Protein is available in 3 different pack sizes.

Is CoV-2 S1 (16-685) Protein in stock?

CoV-2 S1 (16-685) Protein is currently made to order / not held in immediate stock. Contact us for lead time.

CoV-2 S1 (16-685) Protein

Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 (16-685 a.a.)

Product Specifications

Product Name Alternative

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, covid19, COVID-19, COVID-19 virus, HCoV-19, Human coronavirus 2019, SARS2, Spike protein S1, Severe acute respiratory syndrome coronavirus 2, 2019-nCoV, S, Peplomer protein

Source

HEK293 Cells

Field of Research

Infectious Disease & Virology

Purity

Greater than 85.0% as determined by SDS-PAGE.

Bioactivity

Measured by its binding ability in a functional ELISA with Human ACE-2.

Form

Sterile Filtered White lyophilized (freeze-dried) powder.

Storage Conditions

Stability: Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA) . Avoid multiple freeze-thaw cycles

Notes

For research use only.

Applications Notes

Viral Antigens- Sars Proteins

Preservative

The CoV-2 S1 (16-685) solution (0.25mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol.

AA Sequence

DGSMVNLTTR TQLPPAYTNS FTRGVYYPDK VFRSSVLHST QDLFLPFFSN VTWFHAIHVS GTNGTKRFDN PVLPFNDGVY FASTEKSNII RGWIFGTTLD SKTQSLLIVN NATNVVIKVC EFQFCNDPFL GVYYHKNNKS WMESEFRVYS SANNCTFEYV SQPFLMDLEG KQGNFKNLRE FVFKNIDGYF KIYSKHTPIN LVRDLPQGFS ALEPLVDLPI GINITRFQTL LALHRSYLTP GDSSSGWTAG AAAYYVGYLQ PRTFLLKYNE NGTITDAVDC ALDPLSETKC TLKSFTVEKG IYQTSNFRVQ PTESIVRFPN ITNLCPFGEV FNATRFASVY AWNRKRISNC VADYSVLYNS ASFSTFKCYG VSPTKLNDLC FTNVYADSFV IRGDEVRQIA PGQTGKIADY NYKLPDDFTG CVIAWNSNNL DSKVGGNYNY LYRLFRKSNL KPFERDISTE IYQAGSTPCN GVEGFNCYFP LQSYGFQPTN GVGYQPYRVV VLSFELLHAP ATVCGPKKST NLVKNKCVNF NFNGLTGTGV LTESNKKFLP FQQFGRDIAD TTDAVRDPQT LEILDITPCS FGGVSVITPG TNTSNQVAVL YQDVNCTEVP VAIHADQLTP TWRVYSTGSN VFQTRAGCLI GAEHVNNSYE CDIPIGAGIC ASYQTQTNSP RRARHHHHHH